Autopsy: The Perfect Metrics That Nobody Funded
Every number was above benchmark. The founder had done everything right. She still could not close. The reason broke something in how I think about fundraising.
Journal
Field notes, presume tests, and insights from the funding trenches.
The Quiet Investors Who Were Always Going to Say Yes
The loudest enthusiasm in a fundraise is almost never where the term sheet comes from. The real buyers operate differently.
The Cofounder Crack
Fundraising does not break cofounder relationships. It reveals the fracture that was already there.
The Lies Founders Tell in Order
There is a sequence. Every founder follows it. Recognizing where you are in the sequence is the first step toward breaking out of it.
The Founder the Company Needs Next
Series A is where VCs stop evaluating what you built and start evaluating who you are becoming. Most founders do not realize the interview has changed.
Nobody Is Coming to Save You
The investor who finally 'gets it' is not out there. The sooner you stop looking, the sooner you fix what is actually broken.
The Moment You Know
Every raise has a turning point. The founders who recognize it early save months. The ones who miss it lose everything.
What You Cannot Say Out Loud
The silence at the center of a struggling fundraise is more dangerous than any investor rejection.
Autopsy: The Series A That Killed the Company
They closed an $8M round after a brutal process. The celebration was the beginning of the end.
Time Kills More Raises Than Metrics
Founders obsess over their numbers. The variable that actually determines outcomes is the one they track least.
The Pattern in Your Passes
Every rejection you receive is diagnostic data. Most founders throw it away. The ones who survive read it like an x-ray.
The Company You Think You Have
After 300+ diagnostics, the pattern is clear: founders raise for a company that exists only in their heads.
The Backchannel: How VCs Talk to Each Other About You
Investors reference-check founders through their network before, during, and after your pitch. Here is how to manage it.
How Founders Lose Deals That Were Already Alive
You got the second meeting. The process was real. Here is where it falls apart.
Decoding the Polite Pass: What VCs Actually Mean
The rejection phrases investors use and what they are really saying.
The Follow-Up That Actually Works
Most founders follow up wrong. Here is what moves investors from maybe to yes.
What VCs Actually Ask Your Customers
The reference calls that make or break your deal. And how to prepare for them.
5 Signs You Should Not Raise Right Now
Sometimes the best fundraising decision is to wait.
The VC Psychological Playbook: 7 Tactics Founders Miss
Investors aren't being malicious. They're just optimizing for information asymmetry.
Presume Test: First-Time Founders Can't Compete
Testing the assumption that repeat founders dominate Series A fundraising.
The Partner Meeting Is Not Your Pitch
Founders optimize for the wrong room. The decision happens before you arrive and after you leave.
The Narrative Gap: Why Technically Superior Products Lose to Weaker Competitors
You built the better product. They raised the bigger round. Here's the strategic failure that explains almost every case.
Autopsy: The Bridge Round Trap
A startup took bridge financing to 'extend runway for Series A.' Eighteen months later, they're still bridging.
Decoding 'Not Right Now': What VCs Actually Mean
The translation guide for soft passes. Learn to read between the lines and know when to move on.
Presume Test: Technical Co-Founder Required
Testing the assumption that non-technical solo founders can't raise Series A.
Template: The Series A Data Room That Closes Deals
A folder-by-folder structure that answers investor questions before they ask them.
The Metrics That Lie
Your dashboard says you're winning. Your investors see something different. Here's why the gap exists.
Autopsy: The Premature Series A Attempt
A seed-stage company with $800K ARR tried to raise Series A. The market taught an expensive lesson.
What VC Partners Actually Discuss After Your Pitch
A peek inside the partner meeting. The three questions that determine your fate.
Presume Test: You Need a Lead Investor First
Testing the assumption that you must secure a lead before approaching other investors.
The Complete Series A Fundraising Guide (2026)
Everything founders need to know about raising Series A in 2026: benchmarks, timelines, metrics, and the mistakes that kill deals.
Template: The VC Follow-Up Sequence That Gets Second Meetings
A proven 4-email sequence for staying top of mind without being annoying.
The Warm Intro Paradox
The founders who need warm intros the most are the ones least likely to get them. Here's how to break the cycle.
Why Investors Pass on Strong Metrics
A founder with $2.4M ARR and 140% NRR got passed over 23 times. The problem wasn't the numbers.
Presume Test: Founder-Led Sales Ceiling
Testing the assumption that founder-led sales must end before Series A.
Series A Benchmarks 2026: The Numbers Behind 47 Successful Raises
Real data from 47 Series A closes in Q4 2025 and Q1 2026. What actually got funded, and at what terms.
Q1 2026 Series A Terms Are Shifting
Pro-rata rights are back on the table. Here's what's actually changing.
The 7 Metrics That Make or Break Your Series A
VCs will ask for 50 metrics. Only 7 actually drive the investment decision. Here's what they are and how to present them.
Autopsy: The Vertical SaaS Raise That Stalled
A $1.8M ARR construction tech startup couldn't close. The unit economics told the story.
The Series A Timeline: What Actually Happens When
A realistic week-by-week breakdown of the Series A process, from first meeting to wire.
The 7 Mistakes That Kill Series A Deals
After 300+ diagnostics, these are the patterns that consistently derail Series A raises.
Template: The Monthly Investor Update That Gets Responses
A proven format for keeping investors warm without wasting their time.